Pharmaceutical Technology10m
Novo Nordisk strikes $1bn deal for Lexicon’s oral obesity drug
Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to oral therapy ...
Behind Amazon MGM’s Jen Salke Ouster and Its Fallout
Yes, there were some big hits like 'Reacher.' But pricey underperformers like 'Lord of the Rings' and 'Citadel' along with little movement on the Bond franchise didn't help, even if, as chief Mike ...
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...